RENAXOME Trademark

Trademark Overview

On Wednesday, November 5, 2025, a trademark application was filed for RENAXOME with the United States Patent and Trademark Office. The USPTO has given the RENAXOME trademark a serial number of 99481785. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Monday, July 20, 2026. This trademark is owned by Personalized Medicine Care Diagnostics (PMCDx). The RENAXOME trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Genetic testing for medical purposes
renaxome

General Information

Serial Number99481785
Word MarkRENAXOME
Filing DateWednesday, November 5, 2025
Status680 - APPROVED FOR PUBLICATION
Status DateMonday, July 20, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesGenetic testing for medical purposes

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 5, 2025
Primary Code044
First Use Anywhere DateFriday, November 1, 2024
First Use In Commerce DateFriday, November 1, 2024

Trademark Owner History

Party NamePersonalized Medicine Care Diagnostics (PMCDx)
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBethesda, MD 20817
US

Trademark Events

Event DateEvent Description
Wednesday, November 5, 2025NEW APPLICATION ENTERED
Thursday, November 6, 2025APPLICATION FILING RECEIPT MAILED
Monday, November 10, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 18, 2026ASSIGNED TO EXAMINER
Tuesday, March 24, 2026NON-FINAL ACTION WRITTEN
Tuesday, March 24, 2026NON-FINAL ACTION E-MAILED
Tuesday, March 24, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 8, 2026ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, July 8, 2026ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, July 15, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 15, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 15, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 17, 2026TEAS PETITION TO REVIVE RECEIVED
Friday, July 17, 2026PETITION TO REVIVE-GRANTED
Friday, July 17, 2026NOTICE OF REVIVAL - E-MAILED
Friday, July 17, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 17, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 17, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 20, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

renaxome purposes medical testing genetic